Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Tegaserod is dosed at 0.05–0.1 mg/kg PO q12h in dogs, per Corroborated 2026-07-31: Washabau RJ, Day MJ, eds. Canine and Feline Gastroenterology. 1st ed. Elsevier Saunders, 2013:729-777. Ch.58 Large Intestine, Table 58-9. doi:10.1016/B978-1-4160-3661-6.00058-4 PMC7152016 - dog, tegaserod 0.05-0.10 mg/kg PO or IV BID, constipation/ileus.. Tegaserod is used in dogs for GI motility disorders / chronic constipation. Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Tegaserod in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Zelnorm
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.05–0.1 mg/kg | q12h | Investigational; short-term trial | GI motility disorders / chronic constipation | Weak | Corroborated 2026-07-31: Washabau RJ, Day MJ, eds. Canine and Feline Gastroenterology. 1st ed. Elsevier Saunders, 2013:729-777. Ch.58 Large Intestine, Table 58-9. doi:10.1016/B978-1-4160-3661-6.00058-4 PMC7152016 - dog, tegaserod 0.05-0.10 mg/kg PO or IV BID, constipation/ileus. |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Partial 5-HT4 receptor agonist that stimulates peristaltic reflex, increases intestinal secretion, and accelerates GI transit.
Cardiovascular risk — restricted availability. Monitor for diarrhea. Investigational in veterinary species for motility disorders.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Tegaserod dose range in dogs, with cited source references: PO 0.05–0.1 mg/kg q12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Tegaserod in dogs: PO.
Cited course lengths for Tegaserod in dogs include: Investigational; short-term trial. Duration depends on the indication — match it to the specific dose rule in the table above.
Tegaserod is indicated in dogs for: GI motility disorders / chronic constipation.
These are general warnings for Tegaserod across species; consult the dog dosing table above for species-specific guidance. Cardiovascular risk — restricted availability. Monitor for diarrhea. Investigational in veterinary species for motility disorders.
Why a species-specific page? Tegaserod pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.